In a new research study published in IJC Heart & Vasculature, a Swedish research team highlights the significant value of MediYoga as an adjunctive treatment method for people suffering from paroxysmal atrial fibrillation. The study shows impressive results in terms of improvements in health-related quality of life and blood pressure in these patients regardless of gender.

Atrial fibrillation, the most common cardiac arrhythmia in adults worldwide, has received increasing attention due to its rising prevalence. Risk factors such as high blood pressure, diabetes, high blood lipids, smoking, obesity and excessive alcohol intake are associated with AF.

Paroxysmal atrial fibrillation, one of the three subgroups of atrial fibrillation, has been shown to be strongly

affect the health-related quality of life of affected patients. Symptoms such as palpitations and emotional distress affect work, social life, and physical and mental health. In addition, previous studies have shown that gender-related differences exist among patients with AF, with women typically experiencing more severe symptoms such as palpitations and anxiety, as well as lower health-related quality of life scores for psychological and mental aspects.

MediYoga as a method (MOSI), which combines mindfulness, breathing techniques, physical movements and meditation, has recently become increasingly recognised for its reported benefits. These include improvements in health-related quality of life and reductions in depression symptoms and atrial fibrillation attacks. 

It is therefore not surprising that more and more people are choosing MediYoga as a complement to traditional treatment.

Maria Wahlström, Med. dr, Leg. Nurse and Associate Professor at Sophiahemmet University, responsible researcher for the study, commented on the results: "Our study represents an important step forward

in understanding how MediYoga can benefit patients with atrial fibrillation. We found that yoga improved mental health and diastolic blood pressure in both men and women with PAF. This is promising and indicates

that the use of MediYoga as a method can play an important role as a complementary treatment method for these patients.

"To our knowledge, this is the first study to evaluate whether both women and men can improve health-related quality of life, blood pressure and heart rate through MediYoga. Our main findings are that the practice improves health-related quality of life and diastolic blood pressure in these patients, regardless of gender"

Pär Krutzén, CEO of the MediYoga Institute, shared the following comment: "We are very excited about the results of this study and its potential to help people living with atrial fibrillation. As a representative of an organisation committed to promoting health and well-being, any high-quality study that demonstrates the positive health effects of MediYoga is a step forward. We continue to work with the medical community to provide high-quality, well-defined and standardised

yoga as a supportive treatment in health care for those who need it."